Retatrutide Pen
LY3437943 (GLP-1/GIP/Glucagon Receptor Triagonist)
Retatrutide Pen (LY3437943 (GLP-1/GIP/Glucagon Receptor Triagonist)) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Pre-filled, pre-reconstituted Retatrutide auto-injector pen. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.
Scientific name
LY3437943 (GLP-1/GIP/Glucagon Receptor Triagonist)
Molecular weight
4735.5 g/mol
Purity
98.7%
Vial size
30mg
DOCUMENTED RESEARCH AREAS
- ▸Pre-filled, pre-reconstituted pen — no mixing required and consistent metered dosing
- ▸Simultaneous GLP-1, GIP, and glucagon receptor activation for broad metabolic impact
- ▸Significant body weight reduction demonstrated in Phase 2 trials (up to ~24%)
- ▸Improves insulin sensitivity and glycaemic control in preclinical and clinical models
- ▸Increases basal metabolic rate through glucagon-mediated thermogenesis
- ▸Reduces hepatic fat accumulation, with potential utility in NAFLD/NASH research
- ▸Suppresses appetite via hypothalamic and gut-brain axis signalling
CITED LITERATURE (PUBMED)
All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human or animal consumption.